ArticleBMJ open2025
Effects of acoustic startle priming on poststroke dysarthria rehabilitation: study protocol for a double-blinded, single-centre randomised controlled trial in China.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDysarthria is one of the most prevalent communication disorders following a stroke, and it can lead to social isolation and depression, significantly hindering rehabilitation progress. Recent studies suggest that acoustic startle priming (ASP) tasks may enhance speech performance and motor initiation through the corticoreticulospinal tract. This has opened up new possibilities for the application of ASP in the rehabilitation of poststroke dysarthria. The aim of this study is to investigate whether ASP can improve rehabilitation outcomes in individuals with poststroke dysarthria. METHODS AND ANALYSIS: This prospective, randomised, controlled clinical trial plans to enrol 48 participants diagnosed with poststroke dysarthria. Participants will be randomly assigned to either the ASP group (n=24) or the control group (n=24). Both groups will undergo 30 min of standard dysarthria rehabilitation training daily, 5 days per week for 2 weeks. The ASP group will receive an additional 30 min articulation training with ASP, while the control group will receive an equivalent 30 min articulation training with normal acoustic stimuli. Speech and voice characteristics will be assessed using Frenchay Dysarthria Assessment, PRAAT software at baseline, 1 week and 2 weeks postintervention. Furthermore, Functional Near Infrared Spectroscopy will be employed during ASP tasks to investigate cortical activation and changes in brain network connectivity. ETHICS AND DISSEMINATION: The study has been approved by the Tongji Hospital Medical Ethics Committee (TJ-IRB202312100). Raw data from this trial will be publicly available on the Public Management Platform for Clinical Research. The findings will be disseminated through international conferences and peer-reviewed journals. TRIAL REGISTRATION NUMBER: ChiCTR2400081279.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.